ABBV vs AMZN: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Amazon.com, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
AbbVie Inc. · Healthcare
$208.05
+4.5% upside to fair value
Grade C
High Quality
VS
Amazon.com, Inc. · Consumer Cyclical
$238.12
+59.3% upside to fair value
Grade B
High Quality
QuantHub Verdict
AMZN has more upside to fair value
(+59.3%).
ABBV trades at a lower forward P/E
(14.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
AMZN |
| Current Price |
$208.05 |
$238.12 |
| Fair Value Estimate |
$217.50 |
$379.40 |
| Upside to Fair Value |
+4.5%
|
+59.3%
|
| Market Cap |
$367.9B |
$2,556.2B |
| Forward P/E |
14.9x
|
32.8x
|
| EV / EBITDA |
16.7x
|
15.9x
|
| Price / Sales |
6.1x
|
3.6x
|
| Price / FCF |
20.9x
|
332.2x
|
| Revenue Growth YoY |
+8.6%
|
+18.4%
|
| Gross Margin |
83.7%
|
50.3%
|
| Operating Margin |
34.7%
|
11.2%
|
| Return on Equity |
-129.24%
|
21.9%
|
| Dividend Yield |
3.2% |
0% |
| FCF Yield |
4.78%
|
0.3%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a leading diversified biopharmaceutical company navigating the post-Humira transition with strong momentum from Skyrizi and Rinvoq in immunology and continued growth in neuroscience. Full-year 2025 revenue reached $61.2 billion with a gross margin of 83.7% and operating margin of 34.7%, demonstrating operational strength despite the ongoing Humira erosion. Management guides to $67 billi…
Amazon.com, Inc. operates as the world's largest e-commerce and cloud computing company, with a diversified revenue base spanning online retail, third-party seller services, AWS cloud, advertising, and subscription services. The business quality is high due to its durable competitive moats including AWS's leadership in cloud infrastructure and Amazon's dominant e-commerce platform. Despite strong…
Accumulation Zones
| Metric |
ABBV |
AMZN |
| Zone Low |
$163.13 |
$284.55 |
| Zone High |
$184.88 |
$322.49 |
| In Buy Zone? |
No
|
Yes
|